The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are: to confirm the superiority of TAU-284 over placebo after
two weeks of administration to pediatric patients with perennial allergic rhinitis and to
investigate safety of TAU-284.